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Owing to the wide applications and significance of phloroglucide analogues in organic synthesis, pharmacology and 
industry, there is considerable interest in the synthesis of these compounds. Nevertheless, there are few methods for 
preparation of these compounds. Here we reported a simple, clean, and highly efficient procedure for the green synthesis of 
tricyclic polyhydroxyl aromatic compounds. Microwave-assisted alkylation reaction between 4-substituted-2, 
6-bis(chloromethyl)phenols and various phenol derivatives, in the presence of zinc oxide (ZnO) in 1-butyl-3-
methylimidazolium hexaflourophosphate ([Bmim]PF6), affords the title compounds in short duration with high yields. We
have synthesized 18 derivatives of the title compounds 3a-3r by this procedure. Chemical structures of all synthesized
compounds have been confirmed by spectrophotometric methods such as IR, NMR and mass spectroscopy. Some of the
synthesized compounds have been screened for their antimicrobial activities. Antifungal and antibacterial activities have
been evaluated against different species of microorganisms including gram positive and gram negative bacteria as well as
fungi. Broth microdilution method as recommended by Clinical and Laboratory Standard Institute has been used for this
purpose. The results show compounds 3i, 3k and 3m have the best antibacterial and antifungal activity against most of the
examined species. Compounds 3b, 3f, 3o, 3p and 3q also show good activity against some species.
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Phloroglucides are a group of polyhydroxy aromatic 
compounds and they have very important applications 
in pharmacology and organic synthesis. The existence 
of key hydroxyl groups in a proper 3-D array makes 
these compounds as potent antimicrobial agents since 
it provides a perfect situation to accommodate metal 
ions of enzymes. Aspidin-BB, Trisaspidin-BBB, 
arzanol, zantrin Z1 and CBHBP are typical examples 
(Figure 1)
1-4
. They are also available from natural 
sources, e.g. ebracteolatain A and B which were 
isolated from Euphorbia ebracteolata Hayata 
5
. In 
addition these compounds were used as veterinary 




A traditional procedure for the synthesis of the title 
compounds involves Baeyer condensation using 
formalin and sulfuric acid. This procedure is restricted 
to preparation of the analogs containing three similar 
phenol rings in which they are obtained in low yields 
as side products
7
. Other conventional procedure 
includes acid (mineral and solid acids) catalyzed 
alkylation of two equivalents of a phenol with 2,6-
bis(hydroxymethyl)phenol derivatives. Although 
using of solid acids reduces environmental pollutions 
and don’t have other problems related with inorganic 
acids, but excess amounts of phenols which should be 
use in these reactions, is still a serious problem
6-10
. 
Another technique for preparing phloroglucide 
derivatives, is the condensation of phenols with 2, 
6-bis(chloromethyl)phenols, in which large excess 
amounts of phenol derivative (20 folds) is needed and 
phenol itself work as catalyst. This autocatalytic 
method is not suitable for phenols which are 
deactivated by ring substituents, intermolecular 
hydrogen bonded or satirically hindered
11
. 
Recently, mineral oxides have verified to be 
valuable in laboratory research due to good activation 
of adsorbed compounds and reaction rate 
enhancement, simpler workup, recyclability of the 
supports, and eco-friendly reaction conditions. Zinc 
oxide (ZnO) is surely one of the most exciting of 




Owing to the fact that microwave irradiation (MW) 
has been used to increase organic reaction rates, some 
organic reactions have been explained using a mixture 
of microwave irradiation and ionic liquids (ILs)
15
. 
Some of the reactions in common organic solvents 




have limitations such as long reaction time, harsh 
reaction conditions and expensive catalysts. This 
justifies the growing interest in ionic liquids over the 
past decades
16
. Taking the above evidences in mind 
and also in extension of our previous study on the 
synthesis of poly-hydroxyl aromatic compounds
9
 and 
adding of ionic liquids to the chemical reaction 
media
16
, we reported herein a clean, facile and rapid 
solvent-free procedure for alkylation reaction of 2, 
6-bis(chloromethyl)phenols and substituted phenols in 
the presence of ZnO-[Bmim]PF6 under microwave 
condition. We also evaluated our new compounds in 
the point of antifungal and antibacterial activities by 
broth micro dilution method. 
 
Experimental Section 
All chemicals were purchased from Merck and 
Fluka companies. Infrared (IR) spectra were run on a 







C NMR spectra were run on a 
Bruker Avanced DPX-250, FT-NMR spectrometer in 
pure deuterated solvent (CDCl3, DMSO-d6 and D2O). 
Chemical shifts are given in the δ scale in part per 
million (ppm) and J in Hz. Mass spectra were 
determined on a Shimadzu GCMS-QP 1000 EX 
instruments at 70 or 20 eV. Microanalyses were 
performed on a Thermofinnigan Flash EA1112-
1CHNS. Microwave assisted reactions were carried 
out using a household microwave oven (Panasonic 
NN-ST757W-1100W, Matsushita Electric Industrial 
Co., Ltd). Melting points were recorded on a Büchi B 
545 apparatus in open capillary tubes and all are 
uncorrected. The progress of reactions was followed 
with TLC using silica gel SILG/UV 254 plates. All 
yields refer to isolated products after chromatography 
or other indicated purification methods. Column 
chromatography was carried out on silica gel 60 
Merck (230-240 mesh) in glass columns (2 or 3 cm 
diameter) using 15-30 grams of silica gel per one 
gram of the crude product. The eluent solvents were 
petroleum ether, ethyl acetate or mixtures of these. 
Solvents for chromatography were purified by 
distillation before use.  
 
General procedure for synthesis of 4-substituted-
2,6-bis(chloromethyl)phenols 2a-d 
A sample of 4-substituted-2,6-bis (hydroxymethyl) 
phenol 1a-d (30 mmol), (prepared according to 
literature reported procedures)
8
, was suspended in 
concentrated hydrochloric acid (37%, 60 mL) and  
the mixture was stirred overnight. The resulting 
suspension was extracted with dichloromethane  
(3×50 mL). The combined dichloromethane phases 
were washed with brine, dried overnight with Na2SO4 
and the liquid was decanted and vacuum evaporated, 
leaving the product which was recrystallized from 




4-Chloro-2,6-bis(chloromethyl)phenol, 2a: Yellow 
crystals. m.p. 88-90ºC. 
1
H NMR (DMSO-d6, 250 
MHz): 4.75 (s, 4H, 2CH2), 7.41 (s, 2H, aromatic), 



























































Scheme I — Synthesis of 4-substituted-2,6-bis(chloromethyl)phenols 
 




(DMSO-d6, 62.9 MHz): 41.34, 122.87, 127.39, 
130.74, 152.39. 
 
4-Bromo-2,6-bis(chloromethyl)phenol, 2b: Yellow 
crystals. m.p. 93-95ºC. 
1
H NMR (DMSO-d6, 250 
MHz): 4.75 (s, 4H, 2CH2), 7.48 (s, 2H, aromatic), 
9.35 (br., 1H, OH, exchangeable with D2O); 
13
C NMR 
(DMSO-d6, 62.9 MHz): 41.28, 110.48, 127.81, 
133.63, 152.88. 
 
4-methyl-2,6-Bis(chloromethyl)phenol, 2c: Yellow 
crystals. m.p. 84-86ºC. 
1
H NMR (CDCl3, 250 MHz): 
2.28 (s, 3H, CH3), 4.66 (s, 4H, 2CH2), 7.09 (s, 2H, 
aromatic), 9.12 (br, 1H, OH, exchangeable with D2O); 
13
C NMR (CDCl3, 62.9 MHz): 20.23, 38.89, 124.98, 
130.51, 131.82, 150.94. 
 
4-Benzyl-2,6-bis(chloromethyl)phenol, 2d: Colorless 
oil. 
1
H NMR (DMSO-d6, 250 MHz): 3.81 (s, 2H, 
CH2), 4.67 (s, 4H, 2CH2Cl), 6.85 (s, 2H, aromatic), 
7.02-7.17 (m, 5H, aromatic), 9.58 (br., 1H, OH, 
exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 
MHz): 41.29, 41.38, 125.33, 126.51, 128.41, 129.72, 
131.09, 135.01, 141.78, 152.23.  
 
General procedure for synthesis of tris-Phenol 
phloroglucide analogs 3a-r 
To a mixture of 4-substituted-2,6-bis(chloromethyl) 
phenol (2a-d, 1 mmol), well-ground ZnO (0.08 g,  
1 mmol) and different substituted phenols (2 mmol),  
1-butyl-3-methylimidazolium hexaflourophosphate 
([Bmim]PF6) (0.05 g) was added and mixed carefully. 
The resulting mixture was then irradiated in a MW 
oven at 220 W for the desired time. Afterward, the 
reaction mixture was cooled to RT and was extracted 
with Et2O (3×30 mL). The organic extracts were then 
combined. After removal of the solvent, the crude 
product was purified by column chromatography on 
silica gel using EtOAc-petroleum ether as eluent. 
After isolating the products and evaporating the 
reminder Et2O from ionic liquid, the ionic liquid 
containing ZnO ([Bmim]PF6-ZnO) was used for the 




(methylene)bis(4-chlorophenol), 3a: Yellow crystals. 
1
H NMR (DMSO-d6, 250 MHz): 3.81 (s, 4H, 2CH2), 
6.77-6.83 (m, 4H, aromatic), 6.99-7.09 (m, 4H, 
aromatic), 8.88 (br., 1H, OH, exchangeable with 
D2O), 9.81 (br., 2H, 2OH, exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 29.58, 116.38, 
122.38, 122.84, 126.87, 127.18, 128.35, 129.43, 
129.52, 151.41, 153.86. Anal. calc. for C20H15Cl3O3 
(409.69): C 58.63; H 3.69, found: C 58.61; H 3.73. 
Mass m/z (%): 409 (M
+
, 13.2). IR (KBr): 3150w, 
3010m, 2980m, 1610s, 1220m. 
 
6,6'-(5-Chloro-2-hydroxy-1,3-phenylene)bis-
(methylene)bis (4-chloro-3-methylphenol), 3b: 
White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 2.19 
(s, 6H, 2CH3), 3.77 (s, 4H, 2CH2), 6.75 (s, 2H, 
aromatic), 6.99 (s, 2H, aromatic), 7.15 (d, J = 8.65 
Hz, 2H, aromatic), 9.67 (br., 3H, 3OH, exchangeable 
with D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 19.3, 
29.17, 114.01, 117.33, 122.59, 125.72, 126.92, 
129.92, 133.81, 135.16, 151.26, 153.66. Anal. calc. 
for C22H19Cl3O3: C 60.36; H 4.37, found: C 60.37; H 
 
 
Scheme II — Synthesis of tris-Phenol phloroglucide analogs 




4.44. Mass m/z (%): 437 (M
+
, 10.0). IR (KBr): 




(methylene)bis (4-allyl-2-methoxyphenol), 3c: 
Light-yellow crystals. 
1
H NMR (CDCl3, 250 MHz): 
3.11 (d, J = 6.6 Hz, 4H, 2CH2), 3.61 (s, 4H, 2CH2), 
3.67 (s, 6H, 2OCH3), 4.81 (dd, J = 16.5, 10.3 Hz, 4H, 
2H2C=C), 5.16 (br., 3H, 3OH, exchangeable with 
D2O), 5.70 (m, 2H,=C(H)-C), 6.54-7.49 (m, 6H, 
aromatic); 
13
C NMR (CDCl3, 62.9 MHz): 30.02, 
40.01, 56.34, 111.36, 115.36, 117.52, 122.67, 124.61, 
125.81, 128.65, 134.01, 138.81, 141.69, 143.02, 
156.37. Anal. calc. for C28H29ClO5: C 69.92; H 6.08, 
found: C 69.98; H 6.10. Mass m/z (%): 480 (M
+
, 
17.4). IR (KBr): 3450w, 3090m, 2950m, 2985m, 
1600m, 1510m, 1450m, 1410m, 1210w, 1200s. 
 
2,2'-(5-Bromo-2-hydroxy-1,3-phenylene)bis-
(methylene)bis(4-fluorophenol), 3d: White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 3.80 (s, 4H, 2CH2), 
6.74-6.86 (m, 6H, aromatic), 6.91 (s, 2H, aromatic), 
9.35 (br., 3H, 3OH, exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 29.69, 110.65, 
113.02, 113.38, 115.44, 115.57, 116.10, 116.46, 
127.64, 127.75, 129.91, 129.99, 151.01, 151.86, 
153.50, 157.22. Anal. calc. for C20H15BrF2O3: C 
57.03; H 3.59, found: C 56.97; H 3.60. Mass m/z (%): 
421 (M
+
, 7.9). IR (KBr): 3188w, 2940w, 1600w, 
1496s, 1446s, 1236m, 1025w. 
2,2'-(5-Bromo-2-hydroxy-1,3-phenylene)bis-
(methylene) dibenzene-1,4-diol, 3e: Light-brown 
crystals. 
1
H NMR (DMSO-d6, 250 MHz): 3.73 (s, 4H, 
2CH2), 6.43-6.64 (m, 6H, aromatic), 6.88 (m, 2H, 
aromatic), 8.61 (br., 2H, 2OH, exchangeable with 
D2O), 8.76 (br., 1H, OH, exchangeable with D2O), 
8.97 (br., 2H, 2OH, exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 29.64, 110.56, 
113.56, 115.49, 116.83, 126.62, 129.64, 130.52, 
146.99, 149.84, 151.65. Anal. calc. for C20H17BrO5: C 
57.57; H 4.11, found: C 57.39; H 3.98. Mass m/z (%): 
417 (M
+
, 37.5). IR (KBr): 3209w, 2353m, 1704m, 
1604s, 1458m, 1373m, 1211s, 1049m, 956s. 
 
6,6'-(5-Bromo-2-hydroxy-1,3-phenylene)bis-
(methylene)bis (4-chloro-3-methylphenol), 3f: 
White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 2.17 
(s, 6H, 2CH3), 3.78 (s, 4H, 2CH2), 6.39-7.17 (m, 6H, 
aromatic), 8.88 (br., 1H, OH, exchangeable with 
D2O), 9.72 (br., 2H, 2OH, exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 19.30, 29.11, 
114.02, 117.34, 122.61, 125.73, 127.66, 129.93, 
133.83, 135.17, 151.74, 153.65. Anal. calc. for 
C22H19BrCl2O3: C 54.80; H 3.97, found: C 54.69; H 
3.58. Mass m/z (%): 482 (M
+
, 7.8). IR (KBr): 3350w, 
3120m, 2952m, 1645m, 1445s, 1245m, 1180m. 
 
6,6'-(5-Bromo-2-hydroxy-1,3-phenylene)bis-
(methylene)bis (4-allyl-2-methoxyphenol), 3g: 
Light-brown crystals. 
1
H NMR (CDCl3, 250 MHz): 
3.34 (d, J = 6.3 Hz, 4H, 2CH2), 3.84 (s, 4H, 2CH2), 
4.38 (s, 6H, 2OCH3), 4.97 (dd, J = 16.8, 10.3 Hz, 4H, 
2 H2C=C), 5.1 (br., 3H, 3OH, exchangeable with 
D2O), 5.9 (m, 2H, 2=C(H)-C), 6.46-7.28 (m, 6H, 
aromatic); 
13
C NMR (CDCl3, 62.9 MHz): 32.48, 
36.97, 56.03, 112.82, 115.82, 115.91, 123.88, 129.17, 
129.32, 129.86, 131.15, 137.20, 144.07, 145.52, 
151.24. Anal. calc. for C28H29BrO5: C 64.00; H 5.56, 
found: C 64.10; H 5.58. Mass m/z (%): 525 (M
+
, 
43.6). IR (KBr): 3450w, 3090m, 2950m, 2985m, 
1600m, 1520m, 1430s, 1420m, 1200w. 
 
2,2'-(2-Hydroxy-5-methyl-1,3-phenylene)bis-
(methylene)bis (4-chlorophenol), 3h: White 
crystals.. m.p
1
H NMR (DMSO-d6, 250 MHz): 2.06 (s, 
3H, CH3), 3.78 (s, 4H, 2CH2), 6.63 (s, 2H, aromatic), 
6.72-6.88 (m, 4H, aromatic), 7.00-7.04 (m, 2H, 
aromatic), 8.31 (s, 1H, OH, exchangeable with D2O), 
9.79 (s, 2H, 2OH, exchangeable with D2O); 
13
C NMR 
(DMSO-d6, 62.9 MHz): 20.30, 29.56, 116.18, 122.32, 
126.38, 126.70, 127.73, 127.98, 128.59, 129.18, 
144.92, 153.71. Anal. calc. for C21H18Cl2O3: C 64.79; 
H 4.66, found: C 64.77; H 4.63. Mass m/z (%): 389 
(M
+
, 15.9). IR (KBr): 3136w, 3027m, 2931w, 1604w, 
1485s, 1421w, 1388w, 1240s. 
 
2,2'-(2-Hydroxy-5-methyl-1,3-phenylene)bis-
(methylene)bis (4-bromophenol), 3i: White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 2.07 (s, 3H, CH3), 
3.81 (s, 4H, 2CH2), 6.66-6.79 (m, 4H, aromatic),  
7.04-7.17 (m, 4H, aromatic), 8.35 (br, 1H, OH, 
exchangeable with D2O), 9.77 (br, 2H, 2OH, 
exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 
MHz): 20.27, 29.48, 110.05, 116.78, 126.88, 127.93, 
128.80, 129.34, 130.02, 132.06, 149.89, 154.16. Anal. 
calc. for C21H18Br2O3: C 52.75; H 3.79, found: C 
52.67; H 3.53. Mass m/z (%): 478 (M
+
, 7.9). IR 




(methylene)bis (4-methylphenol), 3j: White 
crystals. 
1
H NMR (DMSO-d6, 250 MHz): 2.06 (s, 3H, 
CH3), 2.14 (s, 6H, 2CH3), 3.82 (s, 4H, 2CH2), 6.67-




6.84 (m, 8H, aromatic), 8.26 (s, 1H, OH, exchangeable 
with D2O), 9.41 (s, 2H, 2OH, exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 20.19, 20.32, 29.73, 
114.70, 126.76, 127.24, 127.43, 127.52, 127.61, 
128.31, 130.70, 149.89, 152.16. Anal. calc. for 
C23H24O3: C 79.28; H 6.94, found: C 79.32; H 7.01. 
Mass m/z (%): 348 (M
+
, 45.3). IR (KBr): 3436w, 
3290w, 2999w, 2921m, 1575s, 1423s, 1340w, 1230m. 
 
6,6'-(2-Hydroxy-5-methyl-1,3-phenylene)bis-
(methylene)bis (4-chloro-3-methylphenol), 3k: 
White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 2.06 
(s, 6H, 2CH3), 2.16 (s, 3H, CH3), 3.76 (s, 4H, 2CH2), 
6.19-7.14 (m, 6H, aromatic), 8.32 (br., 1H, OH 
exchangeable with D2O), 9.71 (br., 2H, 2OH, 
exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 
MHz): 19.25, 20.25, 29.15, 117.17, 122.57, 126.83, 
126.88, 127.09, 128.57, 129.64, 133.29, 150.02, 
153.48. Anal. calc. for C23H22Cl2O3: C 66.19; H 5.31, 
found: C 66.05; H 5.24. Mass m/z (%): 417 (M
+
, 6.7). 




(methylene)bis (4-octylphenol), 3l: White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 0.83 (t, J = 6.2 Hz, 
6H, 2CH3), 1.23 (m, 24H, 12CH2), 2.04 (s, 3H, CH3), 
2.3 (t, J = 7.5 Hz, 4H, 2CH2), 3.8 (s, 4H, 2CH2),  
6.64-6.81 (m, 8H, aromatic), 9.2 (br., 3H, 3OH, 
exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 
MHz): 14.11, 20.32, 22.73, 29.32, 29.47, 29.55, 
29.65, 31.76, 31.97, 35.11, 114.71, 126.79, 127.18, 
127.36, 127.51, 127.55, 128.26, 130.68, 149.87, 
152.15. Anal. calc. for C37H52O3: C 81.57; H 9.62, 
found: C 81.62; H 9.70. Mass m/z (%): 544 (M
+
, 
72.3). IR (KBr): 3240w, 3140s, 2930m, 1620m, 
1500s, 1430m, 1220s, 725w. 
 
4,4'-(2-Hydroxy-5-methyl-1,3-phenylene)bis-
(methylene) dibenzene-1,3-diol, 3m: White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 2.06 (s, 3H, CH3), 
3.65 (s, 4H, 2CH2), 6.17 (d, J = 8.0 Hz, 2H, aromatic), 
6.28 (s, 2H, aromatic), 6.49 (s, 2H, aromatic), 6.75 (d, 
J = 8.0 Hz, 2H, aromatic), 9.02 (s, 2H, 2OH, 
exchangeable with D2O), 9.16 (s, 1H, OH, 
exchangeable with D2O), 9.36 (br., 2H, 2OH, 
exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 
MHz): 20.36, 28.99, 102.21, 106.25, 117.35, 127.24, 
127.82, 127.95, 130.64, 149.68, 155.11, 156.33. Anal. 
calc. for C21H20O5: C 71.58; H 5.72, found: C 71.67; 
H 5.79. Mass m/z (%): 352 (M
+
, 69.4). IR (KBr): 
3255w, 2931w, 1604s, 1396w, 1288m, 1226m, 
1095m, 833s. 
2,2'-(5-Benzyl-2-hydroxy-1,3-phenylene)bis-
(methylene)bis (4-chlorophenol), 3n: White 
crystals. 
1
H NMR (DMSO-d6, 250 MHz): 3.74 (s, 2H, 
CH2), 3.85 (s, 4H, 2CH2), 6.81-7.25 (m, 13H, 
aromatic), 8.34 (br., 1H, OH, exchangeable with 
D2O), 9.87 (br., 2H, 2OH, exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 29.68, 40.41, 
116.18, 122.43, 125.66, 126.41, 126.96, 128.19, 
128.36, 129.04, 129.16, 129.41, 131.95, 141.74, 
150.86, 153.71. Anal. calc. for C27H22Cl2O3: C 69.68; 
H 4.76, found: C 69.47; H 4.33. Mass m/z (%): 465 
(M
+
, 11.4). IR (KBr): 3236w, 3127m, 2910w, 1614w, 
1455s, 1420w, 1366w, 1240s. 
 
2,2'-(5-Benzyl-2-hydroxy-1,3-phenylene)bis-
(methylene)bis (4-bromophenol), 3o: White 
crystals. 
1
H NMR (DMSO-d6, 250 MHz): 3.74 (s, 2H, 
CH2), 3.85 (s, 4H, 2CH2), 6.78-7.26 (m, 13H, 
aromatic), 9.72 (br, 3H, 3OH, exchangeable with 
D2O); 
13
C NMR (DMSO-d6, 62.9 MHz): 29.58, 40.39, 
110.12, 116.77, 125.66, 126.95, 128.21, 128.34, 
129.05, 129.34, 129.99, 131.89, 131.99, 141.74, 
150.84, 154.18. Anal. calc. for C27H22Br2O3: C 58.51; 
H 4.00, found: C 58.37; H 3.73. Mass m/z (%): 554 
(M
+
, 27.1). IR (KBr): 3430w, 3125m, 2945w, 1620w, 
1475m, 1421w, 1380m, 1242s. 
 
2,2'-(5-Benzyl-2-hydroxy-1,3-phenylene)bis-
(methylene)bis (4-fluorophenol), 3p: Brown oil. 
1
H NMR (CDCl3, 250 MHz): 3.89-4.06 (m, 6H, 
3CH2), 6.86-7.46 (m, 13H, aromatic), 8.96 (br., 3H, 
3OH, exchangeable with D2O); 
13
C NMR (CDCl3, 
62.9 MHz): 29.12, 41.15, 114.24, 114.61, 116.86, 
116.91, 126.31, 126.36, 127.11, 127.36, 128.03, 
128.69, 128.73, 129.02, 129.79, 130.06, 134.82, 
141.43, 147.95, 155.63, 159.43. Anal. calc. for 
C27H22F2O3: C 74.99; H 5.13, found: C 75.23; H 5.03. 
Mass m/z (%): 432 (M
+
, 9.5). IR (KBr): 3350m, 
3055m, 2915m, 1614m, 1485m, 1385, 1210s. 
 
2,2'-(5-Benzyl-2-hydroxy-1,3-phenylene)bis-
(methylene)bis (4-methoxyphenol), 3q: White 
crystals. 
1
H NMR (CDCl3, 250 MHz): 3.58 (s, 6H, 
2OCH3), 3.74 (s, 4H, 2CH2), 3.77 (s, 2H, CH2), 6.41-
7.17 (m, 13H, aromatic), 8.55 (br., 2H, 2OH, 
exchangeable with D2O), 9.28 (br., 1H, OH, 
exchangeable with D2O); 
13
C NMR (CDCl3, 62.9 
MHz): 31.82, 41.02, 55.73, 113.00, 116.09, 116.79, 
126.08, 127.62, 128.33, 128.48, 128.93, 129.74, 
134.34, 141.40, 145.83, 148.22, 154.12. Anal. calc. 
for C29H28O5: C 76.30; H 6.18, found: C 76.25;  
H 6.08. Mass m/z (%): 456 (M
+
, 100.0). IR (KBr): 








(methylene)bis (4-chloro-3-methylphenol), 3r: 
White crystals. 
1
H NMR (DMSO-d6, 250 MHz): 2.18 
(s, 6H, 2CH3), 3.46 (s, 2H, CH2), 3.78 (s, 4H, 2CH2), 
6.25-7.24 (m, 11H, aromatic), 8.40 (br., 1H, OH, 
exchangeable with D2O), 9.71 (br., 2H, 2OH, 
exchangeable with D2O); 
13
C NMR (DMSO-d6, 62.9 
MHz): 19.27, 29.24, 40.37, 113.87, 117.15, 122.59, 
122.62, 125.58, 125.62, 127.15, 128.08, 128.17, 
128.21, 129.53, 133.28, 150.60, 153.49. Anal. calc. 
for C29H26Cl2O3: C 70.59; H 5.31, found: C 70.43;  
H 5.28. Mass m/z (%): 493 (M
+
, 14.4). IR (KBr): 





Antifungal activities of the synthetic compounds 
against some American Type Culture Collection 
(ATCC) strains of fungi, including Candida albicans 
(ATCC 10261), Candida glabarata (ATCC 90030), 
Candida dubliniensis (CBS 8501), Candida krusei 
(ATCC 6258), Candida parapsilosis (ATCC 4344), 
Candida tropicalis (ATCC 750), Cryptococcus 
neoformane (ATCC 9011), Aspergillus flavus (ATCC 
64025) and Aspergillus fumigatus (ATCC 14110) 
were determined. The susceptibility of all clinical 
isolates of fungi against selected compounds was 
examined by micro dilution method. The antibacterial 
activities of the above compounds against  
standard species of Escherichia coli (ATCC 25922), 
Staphylococcus aureus (ATCC 25923), Enterococcus 
faecalis (ATCC 11700) and Pseudomonas aeruginosa 
(ATCC 27853) were also determined in this study. 
The susceptibility of all clinical isolates of  
bacteria against selected compounds was examined  
by microdilution method
18,19
. Fluconazole and 
ciprofloxacin were used as positive control for 
antifungal and antibacterial activities respectively. 
 
Determination of minimum inhibitory concentration 
MICs were determined using the broth 
microdilution method recommended by the CLSI with 
some modifications. Briefly, for determination of an-
timicrobial activities against fungi, serial dilutions of 
the synthetic compounds (1-256 μg/mL) were 
prepared in 96-well microtiter plates using RPMI-
1640 media (Sigma, St. Louis, MO, USA) buffered 
with MOPS (Sigma). Stock inoculums were prepared 
by suspending three colonies of the examined yeast in 
5 mL sterile 0.85% NaCl, and adjusting the turbidity 
of the inoculums to 0.5 McFarland standards at  
530 nm wavelengths (this yields stock suspension  
of 1-5 × 10
6
 cells/mL). For moulds, conidia were 
recovered from the 7-day old cultures grown on 
potato dextrose agar by a wetting loop with tween-20. 
The collected conidia were transferred in sterile saline 
and their turbidity was adjusted to OD=0.09-0.11 that 
yields 0.4-5 × 10
6
 conidia/mL. Working suspension 
was prepared by making a 1/50 and 1/1000 dilution 
with RPMI of the stock suspension for moulds and 
yeasts, respectively. Working inoculums (0.1 mL) 
were added to the microtiter plates, which were 
incubated in a humid atmosphere at 30ºC for 24-48 h. 
Uninoculated medium (200 μL) was included as a 
sterility control (blank). In addition, growth controls 
(medium with inoculums but without antibiotics or 
the synthetic compounds) were also included. The 
growth in each well was compared with that of the 






Optimization of the reaction conditions 
To optimize the reaction conditions, condensation 
of 4-chlorophenol (5 mmol) with 4-chloro-2,6-bis 
(chloromethyl)phenol 2a was studied as a model 
reaction to provide compound 3a (Scheme III). 
The efficiency of several mediums was first 
examined in the presence of ZnO (1 mmol) under 
microwave irradiation (200 Watt) and 0.2 g of different 
ionic liquids or tetraalkylammonium salts. The results 
are collected in Table I. As shown in Table I, the best 
result was observed when ([Bmim]PF6) was used as 
medium (entry 4) and compound 3a was obtained in 
91% yield in 2 minutes. The catalytic power of the ILs is 
markedly influenced by the counter ion, a decrease in 
 
 
Scheme III — Synthesis of 3a in order to optimize the reaction conditions 




the catalytic efficiency was observed in the case of 
tetraalkylammonium-based salts. 
In the next experiment, to determine the optimum 
amount of ionic liquid, we examined the effect of 
different amounts of ([Bmim]PF6) on the model 
reaction (Table II). Our results showed that 0.05 g of 
([Bmim]PF6) (entry 4) had the best activity for 
production of 3a. 
In the next step to examine the efficiency of ZnO 
comparative to other mineral oxides, we performed 
the model reaction using various catalysts (1 mmol) 
instead of ZnO (Table III). As shown in Table III, 
ZnO was the best catalyst for completion of the 
reaction (entry 2). Other catalysts afforded low yields 
of the product. Thus, ZnO was selected as the catalyst 
of choice in all further reactions. 
Then to obtain the optimized amount of the ZnO, 
we examined different amounts of catalyst in the 
reaction. The results are summarized in Table IV. 
These data shows, that the best isolated yield of the 
product was obtained using 1 mmol of ZnO (entry 2). 
Finally, to establish the best ratio of substituted 
phenols toward 1 mmol of bis(chloromethyl)phenol 
2a, we performed the model reaction in the presence 
of different ratio of this starting material (Table V). 
The best results were obtained when 2 mmol  
of substituted phenols was used per 1 mmol of 2a  
(entry 5). Therefore, we decided to extend the scope 
of the reaction using 2 mmol of phenols, matching 
benign with atom economic processes. 
These conditions were then applied to run all the 
subsequent reactions. To evaluate the  generality  and  
scope of the above procedure, a variety of  
2,6-bis(chloromethyl)phenols 2a-d and different 
substituted phenols with electron donating and 
electron withdrawing groups were introduced to the 
optimized reaction conditions. All the reactions 
proceeded in mild conditions under microwave 
irradiation with good to excellent yields. The results 
are summarized in Table VI. In all these cases, the 
reaction proceeded quickly and the desired products 




Antimicrobial activities of the synthetic derivatives 
Some of the synthesized compounds were screened 
for antimicrobial activities and the results are 
summarized in Table VII. According to our results, 
compounds 3k and 3m exhibited considerable 
antifungal activities against most of the tested yeasts 
at concentration of 1-128 μg/mL. Compound 3b 
showed desirable antifungal activities against  
C. albicans, C. glabrata and C. tropicalis at 
concentration 16-64 μg/mL. Compound 3i showed 
desirable antifungal activities against C. parapsilosis 
at concentration 8-16 μg/mL. Compound 3o showed 
desirable antifungal activities against C. albicans,  
C. krusei and C. tropicalis at concentration 1-64 μg/mL. 
Table II — Effect of different amounts of ([Bmim]PF6) for 
synthesis of compound 3a 
Entry Weight (g) Time (min:sec) Yield (%) 
1 0.2 1:30 91 
2 0.15 1:30 92 
3 0.1 1:30 94 
4 0.05 2:00 95 
5 0.02 2:00 90 
 
Table III — Effect of different catalysts for synthesis of 
compound 3a 
Entry Catalyst Time (min:sec) Yield (%) 
1 CaO 15:00 25 
2 ZnO 2:00 91 
3 TiO2 10:00 56 
4 Al2O3 20:00 32 
 
Table IV — Effect of different amounts of ZnO for synthesis of 
compound 3a 
Entry mmol Time (min:sec) Yield (%) 
1 1.5 1:40 87 
2 1.0 2:00 91 
3 0.75 1:00 85 
4 0.5 1:30 81 
 
Table V — Effect of different ratio of substituted phenols toward 
1 mmol of 2a 
Entry mmol Time (min:sec) Yield (%) 
1 5 2:00 91 
2 4 1:40 92 
3 3 1:40 94 
4 2.5 1:30 95 
5 2 2:00 95 
 
Table I — Effect of different mediums for synthesis of  
compound 3a 
Entry Medium Time (min:sec) Yield (%) 
1 [Bmim]Br 1:00 85 
2 [Bmim]Cl 2:10 81 
3 [Bmim]BF4 1:40 85 
4 [Bmim]PF6 2:00 91 
5 [Bmim]OAc 1:30 57 
6 [Bmim]HSO4 1:30 41 
7 TBAB 1:00 76 
8 TBAC 1:00 77 
9 TBAI 1:20 61 
10 TEAB 2:15 53 
 




Compound 3r showed desirable antifungal activities 
against C. albicans at concentration 4 μg/mL. 
The antibacterial activities of the synthesized 
compounds were also evaluated. The results are 
summarized in Table VIII. Compounds 3f, 3i, 3p  
and 3q showed desirable antibacterial activities 
against E. fecalis and P. aeruginosa at concentration  
0.5-32 μg/mL. 
Based on the results displayed in Table VI, it is 
clear that both electron donating and electron 
withdrawing substituents on the phenol rings are 
suitable for this reaction. In the reaction of different 
substituted phenols versus p-cresol (Table VI, entries 
3h-m) the lower yield is related to 3l which is 
suggested to be because of the bulkiness of n-octyl 
group. This method was also examined for an 
asymmetric phenol (4-chloro-3-methyl) which has 
two different ortho sites adjacent to its hydroxyl 
(Table VI, entries 3b, 3f, 3k and 3r). As the results 
indicate, these derivatives also alkylated selectively in 
less hindered ortho site with good to excellent yields. 
Moreover, this method was suitable for the 
condensation of acid sensitive phenols such as 
eugenol which is prone to double bond migration  and 
conversion to its more stable isomer (isoeugenol)  
in acidic media (Table VI, entries 3c and 3g).  
It is suggested that, the higher condensation  
rates encouraged by ionic liquid compared to the 
Table VI — Chemical structures of the synthesized compounds 3a-r using optimized reaction conditions 
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competing isomerization reaction which is much 
slower in the neutral medium is the cause for progress 
of the desired reaction. 
Alkyl and alkoxy substituted phenols such as  
p-cresol (3j) and p-n-octylphenol (3l) and p-methoxy 
phenol (3q) were also used and the products were 
obtained in good to excellent yields.  
 
Conclusion 
In conclusion, we have introduced a highly 
efficient procedure for ionic-liquid-accelerated 
alkylation reaction of 4-substituted-2,6-bis (chloromethyl) 
phenols with different substituted phenols under 
microwave irradiation. The promising points for the 
presented methodology are high conversion, ease of 
handling and low cost of ZnO, cleaner reaction 
profile, and short reaction times. These properties 
make our procedure a useful and attractive process for 
the rapid synthesis of tricyclic polyhydroxy aromatic 
compounds as biologically interesting compounds. 
Some of the synthesized compounds were screened 
for possibly antimicrobial activity. In compare to 
standard drugs our compounds showed moderate to 
good antifungal and antibacterial activities.  
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